[Clinical trial of an association of 5-chlorobenzoxazolinone and N-acetyl-para-aminophenol (Parafon)].
D000083:Acetanilides / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001416:Back Pain / Q000188:drug therapy; D001583:Benzoxazoles / Q000627:therapeutic use*; D006261:Headache / Q000188:drug therapy; D006801:Humans; D009467:Neuromuscular Depolarizing Agents / Q000627:therapeutic use*; D012585:Sciatica / Q000188:drug therapy*; D013122:Spinal Diseases / Q000188:drug therapy*; D014103:Torticollis / Q000188:drug therapy
D000083:Acetanilides; D001583:Benzoxazoles; D009467:Neuromuscular Depolarizing Agents
Considerations sur l'expérimentation clinique d'une association entre le 5-chlorobenzoxazolinone et le N-acetyl-para-aminaphenol (Parafon)